Results
3043
Most Popular Stocks on the market
3043 companies
Shanghai Kai Kai Industry
Market Cap: CN¥2.6b
Engages in the production, distribution, and sale of pharmaceutical and clothing products in China.
600272
CN¥12.70
7D
-3.0%
1Y
11.9%
Pyridam Farma
Market Cap: Rp6.1t
Engages in the development, production, and trading of pharmaceuticals primarily in Indonesia.
PYFA
Rp545.00
7D
15.0%
1Y
147.7%
Vimta Labs
Market Cap: ₹32.6b
Provides contract research and testing services in India and internationally.
524394
₹731.10
7D
-11.3%
1Y
165.6%
Lexeo Therapeutics
Market Cap: US$365.6m
A clinical stage genetic medicine company, focuses on hereditary and acquired diseases with high unmet need in the United States.
LXEO
US$6.77
7D
31.5%
1Y
-25.7%
Pacific Biosciences of California
Market Cap: US$363.4m
Designs, develops, and manufactures sequencing solution to resolve genetically complex problems.
PACB
US$1.21
7D
-4.7%
1Y
-30.9%
Xinjiang Tianshan Animal Husbandry Bio-engineering
Market Cap: CN¥2.6b
Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd.
300313
CN¥8.26
7D
-4.1%
1Y
33.4%
ShanXi C&Y Pharmaceutical GroupLTD
Market Cap: CN¥2.6b
Engages in the research, development, production, and sale of medicine and health food products.
300254
CN¥10.39
7D
-2.1%
1Y
24.0%
Benitec Biopharma
Market Cap: US$359.6m
A clinical-stage biotechnology company, focuses on the development of novel genetic medicines.
BNTC
US$13.70
7D
1.9%
1Y
48.4%
DiaMedica Therapeutics
Market Cap: US$358.7m
A clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases.
DMAC
US$6.94
7D
1.8%
1Y
66.0%
Race Oncology
Market Cap: AU$544.0m
A clinical stage biopharmaceutical company, focuses on addressing the unmet needs of cancer patients for damaging treatments.
RAC
AU$3.13
7D
1.0%
1Y
76.3%
Hangzhou Jiuyuan Genetic Biopharmaceutical
Market Cap: HK$2.8b
A biopharmaceutical company, engages in the research, development, production, and sale of biopharmaceutical products and medical devices.
2566
HK$11.28
7D
-6.0%
1Y
n/a
Clover Biopharmaceuticals
Market Cap: HK$2.8b
A biotechnology company, engages in the research and development, manufacture, and commercialization of vaccines in Mainland China and internationally.
2197
HK$2.13
7D
8.1%
1Y
647.4%
Mesa Laboratories
Market Cap: US$354.9m
Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.
MLAB
US$64.51
7D
-11.8%
1Y
-49.5%
Hikal
Market Cap: ₹31.4b
Manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, biotechnology, life sciences, animal health, crop protection, and specialty chemicals indusries.
524735
₹254.80
7D
-5.3%
1Y
-31.4%
Altimmune
Market Cap: US$353.0m
A clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases.
ALT
US$4.00
7D
5.8%
1Y
-38.2%
Cullinan Therapeutics
Market Cap: US$352.1m
A clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States.
CGEM
US$5.96
7D
-3.9%
1Y
-65.3%
Rocket Pharmaceuticals
Market Cap: US$351.8m
Operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases in the United States.
RCKT
US$3.26
7D
6.2%
1Y
-82.3%
Guiyang Xintian PharmaceuticalLtd
Market Cap: CN¥2.5b
Engages in the research and development, production, and sale of new Chinese patent medicines in China.
002873
CN¥10.62
7D
-2.7%
1Y
16.1%
Hansa Biopharma
Market Cap: SEK 3.3b
A biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe.
HNSA
SEK 38.82
7D
12.0%
1Y
-4.8%
Senores Pharmaceuticals
Market Cap: ₹31.0b
Develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally.
SENORES
₹673.60
7D
-5.4%
1Y
n/a
Guangdong Lifestrong Pharmacy
Market Cap: CN¥2.5b
Engages in the research, development, production, and sale of pharmaceutical products.
301111
CN¥15.51
7D
-3.1%
1Y
4.4%
Shanghai Serum Bio-Technology
Market Cap: CN¥2.5b
Engages in the research, development, production, operation, and sale of antitoxin and antiserum products in China.
688163
CN¥22.93
7D
-3.6%
1Y
39.1%
LB Pharmaceuticals
Market Cap: US$346.5m
A clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases.
LBRX
US$15.44
7D
-2.8%
1Y
n/a
Zhejiang Xinguang Pharmaceutical
Market Cap: CN¥2.5b
Zhejiang Xinguang Pharmaceutical Co., Ltd.
300519
CN¥15.44
7D
-2.1%
1Y
28.6%
Ginwa Enterprise (Group)
Market Cap: CN¥2.5b
Researches, develops, produces, and sells pharmaceuticals in China.
600080
CN¥7.00
7D
-1.3%
1Y
12.4%
JW Pharmaceutical
Market Cap: ₩487.2b
Manufactures and sells medicines and medical supplies in Japan and internationally.
A001060
₩21,200.00
7D
-5.1%
1Y
-25.7%
Hubei Goto BiopharmLtd
Market Cap: CN¥2.5b
Engages in the research, development, production, and sale of steroid drug raw materials and intermediates in China and internationally.
300966
CN¥21.38
7D
-0.7%
1Y
34.5%
Flerie
Market Cap: SEK 3.2b
A venture capital firm specializing in early-stage investments.
FLERIE
SEK 41.80
7D
0.5%
1Y
-0.5%
EuBiologics
Market Cap: ₩484.5b
A biopharmaceutical company, provides vaccines for pidemics in South Korea.
A206650
₩13,230.00
7D
-6.4%
1Y
12.1%
IOL Chemicals and Pharmaceuticals
Market Cap: ₹30.5b
Manufactures and sells pharmaceutical and chemical products in India and internationally.
524164
₹103.87
7D
-13.4%
1Y
9.1%
Inventage Lab
Market Cap: ₩480.9b
Inventage Lab Inc., a platform technology company, develops medicines using microfluidics based drug delivery systems.
A389470
₩44,700.00
7D
-15.5%
1Y
122.9%
Tvardi Therapeutics
Market Cap: US$340.6m
A clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need in the United States.
TVRD
US$36.32
7D
-5.0%
1Y
n/a
Sailong Pharmaceutical GroupLtd
Market Cap: CN¥2.4b
Sailong Pharmaceutical Group Co., Ltd. researches, develops, produces, markets, and services pharmaceutical intermediates, raw materials, and preparations in China.
002898
CN¥13.80
7D
-2.2%
1Y
39.4%
Acepodia
Market Cap: NT$10.3b
Operates as a clinical stage biotechnology company.
6976
NT$17.65
7D
3.5%
1Y
-25.8%
Chengdu huasun technology group
Market Cap: CN¥2.4b
Chengdu huasun technology group Inc. , LTD.
000790
CN¥3.83
7D
-2.8%
1Y
2.4%
Contineum Therapeutics
Market Cap: US$334.3m
A clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications with high unmet need in the United States.
CTNM
US$11.92
7D
-4.6%
1Y
-36.7%